Rebecca A. Sendak

785 total citations
15 papers, 395 citations indexed

About

Rebecca A. Sendak is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rebecca A. Sendak has authored 15 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rebecca A. Sendak's work include Thyroid Disorders and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Bone health and osteoporosis research (3 papers). Rebecca A. Sendak is often cited by papers focused on Thyroid Disorders and Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Bone health and osteoporosis research (3 papers). Rebecca A. Sendak collaborates with scholars based in United States, France and Switzerland. Rebecca A. Sendak's co-authors include André Bensadoun, John M. McPherson, T. Kuber Sampath, Slobodan Vukičević, Susan C. Schiavi, Petra Šimić, Stephen O’Brien, Nataša Drača, Kristan Melford and A. S. Kao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Analytical Chemistry and Neurology.

In The Last Decade

Rebecca A. Sendak

14 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca A. Sendak United States 9 201 173 100 70 58 15 395
Andrzej Surus New Zealand 7 168 0.8× 155 0.9× 66 0.7× 82 1.2× 10 0.2× 8 395
M J McKay United Kingdom 10 146 0.7× 232 1.3× 81 0.8× 19 0.3× 40 0.7× 18 432
Linjie Yang China 11 43 0.2× 166 1.0× 39 0.4× 36 0.5× 24 0.4× 33 307
T. V. Gudmundsson United Kingdom 8 123 0.6× 143 0.8× 68 0.7× 11 0.2× 9 0.2× 11 377
Yehani Wedatilake United Kingdom 10 37 0.2× 329 1.9× 52 0.5× 12 0.2× 19 0.3× 18 570
Gerry Steenbergen Netherlands 5 47 0.2× 174 1.0× 57 0.6× 4 0.1× 17 0.3× 6 333
Chiaoyun Benson Kuo United States 8 185 0.9× 147 0.8× 92 0.9× 30 0.4× 2 0.0× 10 345
Sindy Rabe Germany 12 86 0.4× 197 1.1× 55 0.6× 2 0.0× 81 1.4× 20 324
A.M. Caswell United Kingdom 10 63 0.3× 108 0.6× 46 0.5× 30 0.4× 4 0.1× 18 311
Kiyoto Sakata Japan 12 19 0.1× 115 0.7× 81 0.8× 13 0.2× 5 0.1× 24 392

Countries citing papers authored by Rebecca A. Sendak

Since Specialization
Citations

This map shows the geographic impact of Rebecca A. Sendak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca A. Sendak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca A. Sendak more than expected).

Fields of papers citing papers by Rebecca A. Sendak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca A. Sendak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca A. Sendak. The network helps show where Rebecca A. Sendak may publish in the future.

Co-authorship network of co-authors of Rebecca A. Sendak

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca A. Sendak. A scholar is included among the top collaborators of Rebecca A. Sendak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca A. Sendak. Rebecca A. Sendak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Schneider, Marion, Dilyana Dimova, Arnd Brandenburg, et al.. (2023). High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass Spectrometry. Analytical Chemistry. 95(27). 10265–10278. 2 indexed citations
2.
Qiu, Huawei, Ronnie R. Wei, Ekaterina Boudanova, et al.. (2019). Engineering an anti-CD52 antibody for enhanced deamidation stability. mAbs. 11(7). 1266–1275. 16 indexed citations
3.
Siders, William, Ronnie R. Wei, Alison McVie‐Wylie, et al.. (2016). GZ402668, a Next-Generation Anti-CD52 Antibody, Displays Decreased Proinflammatory Cytokine Release In Vitro (P3.068). Neurology. 86(16_supplement). 3 indexed citations
4.
Siders, William, Alison McVie‐Wylie, Vijay Dhawan, et al.. (2015). Characterization of a Next Generation Anti-CD52 Antibody (S20.006). Neurology. 84(14_supplement). 1 indexed citations
5.
Sun, Li, Slobodan Vukičević, Ramkumarie Baliram, et al.. (2008). Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proceedings of the National Academy of Sciences. 105(11). 4289–4294. 97 indexed citations
6.
Sampath, T. Kuber, Petra Šimić, Rebecca A. Sendak, et al.. (2007). Thyroid-Stimulating Hormone Restores Bone Volume, Microarchitecture, and Strength in Aged Ovariectomized Rats*. Journal of Bone and Mineral Research. 22(6). 849–859. 109 indexed citations
7.
Sendak, Rebecca A., T. Kuber Sampath, & John M. McPherson. (2007). Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodelling. International Orthopaedics. 31(6). 753–757. 17 indexed citations
8.
Huff, Michael R., Kerry Culm-Merdek, Robert Fogle, et al.. (2007). Pharmacokinetics and pharmacodynamics following low dose TSH administration in aged ovariectomized rats. The FASEB Journal. 21(5).
9.
Fu, Daotian, et al.. (2006). Development of an in vitro potency assay for therapeutic TGFβ antagonists: The A549 cell bioassay. Journal of Immunological Methods. 316(1-2). 18–26. 14 indexed citations
10.
Sendak, Rebecca A., Chandrashekar Ganesa, Roger Théberge, et al.. (2003). The Effect of Posttranslational Modifications on the In Vitro Activity of Recombinant Human Thyroid-Stimulating Hormone. Thyroid. 13(12). 1091–1101. 5 indexed citations
11.
Sendak, Rebecca A., et al.. (2002). Comparison of Two In Vitro Methods for the Measurement of Recombinant Human TSH Bioactivity. Biologicals. 30(3). 245–254. 8 indexed citations
12.
Sendak, Rebecca A., et al.. (2000). Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters. Journal of Lipid Research. 41(2). 260–268. 20 indexed citations
13.
Sendak, Rebecca A. & André Bensadoun. (1998). Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis. Journal of Lipid Research. 39(6). 1310–1315. 54 indexed citations
14.
Sendak, Rebecca A., Kristan Melford, A. S. Kao, & André Bensadoun. (1998). Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparin-binding domain. Journal of Lipid Research. 39(3). 633–646. 22 indexed citations
15.
Sendak, Rebecca A., David M. Rothwarf, William J. Wedemeyer, Walid A. Houry, & Harold A. Scheraga. (1996). Kinetic and Thermodynamic Studies of the Folding/Unfolding of a Tryptophan-Containing Mutant of Ribonuclease A. Biochemistry. 35(39). 12978–12992. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026